相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications
Muhammet Oner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
NF-kappa B2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer
Nagalakshmi Nadiminty et al.
MOLECULAR CANCER THERAPEUTICS (2015)
PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion
Joshua D. Brown-Clay et al.
ONCOTARGET (2015)
A Naturally Derived Small Molecule Disrupts Ligand-Dependent and Ligand-Independent Androgen Receptor Signaling in Human Prostate Cancer Cells
Karishma S. Amin et al.
MOLECULAR CANCER THERAPEUTICS (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer
Jean Hoffman-Censits et al.
CLINICAL CANCER RESEARCH (2013)
Posttranslational Modification of the Androgen Receptor in Prostate Cancer
Travis van der Steen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Abiraterone in Prostate Cancer: A New Angle to an Old Problem
Mark N. Stein et al.
CLINICAL CANCER RESEARCH (2012)
Androgen receptor (AR) aberrations in castration-resistant prostate cancer
Kati K. Waltering et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Abiraterone acetate for prostate cancer: a new era of hormonal therapies
Emmanuel S. Antonarakis
ASIAN JOURNAL OF ANDROLOGY (2011)
The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line
Igor Tsaur et al.
CANCER LETTERS (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5
Fu-Ning Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
Critical roles of T-LAK cell-originated protein kinase in cytokinesis
Jae-Hyun Park et al.
CANCER SCIENCE (2010)
CDK9 Regulates AR Promoter Selectivity and Cell Growth through Serine 81 Phosphorylation
Vicki Gordon et al.
MOLECULAR ENDOCRINOLOGY (2010)
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
F. Hu et al.
ONCOGENE (2010)
Pleiotropic Functional Properties of Androgen Receptor Mutants in Prostate Cancer
Jean-Pierre Bergerat et al.
HUMAN MUTATION (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions
Chun-Song Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
Shaoyong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase
JD Dougherty et al.
JOURNAL OF NEUROSCIENCE (2005)
Characterization of a MAPKK-like protein kinase TOPK
S Matsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase
HK Lin et al.
EMBO JOURNAL (2002)
PDZ-binding kinase participates in spermatogenesis
SH Zhao et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
Characterization of PDZ-binding kinase, a mitotic kinase
S Gaudet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
